dr. robertson on olaparib for serous ovarian cancer
Published 11 years ago • 660 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:15
dr. robson on the toxicity profile of olaparib in breast cancer
-
11:22
olaparib in ovarian cancer
-
1:15
dr. jane robertson on the mechanism of action of olaparib
-
1:25
olaparib in ovarian cancer
-
1:20
dr. ledermann discusses olaparib in ovarian cancer
-
2:12
dr. patel on an analysis of olaparib and cediranib for ovarian cancer
-
1:19
dr. grisham on frontline treatment for low-grade serous ovarian cancer
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
2:40
update on study 19 trial of olaparib in serous ovarian cancer
-
0:53
dr. annunziata on olaparib and cediranib combination in ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
1:40
neo trial: neoadjuvant olaparib in platinum-sensitive relapsed high-grade serous ovarian cancer
-
1:48
dr. penson on olaparib monotherapy vs chemo for ovarian cancer
-
0:54
dr. charlie gourley on olaparib maintenance in ovarian cancer
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
2:21
olaparib: predicting response in breast cancer
-
2:21
dr. rafii discusses clinical outcomes with olaparib in patients with ovarian cancer